CeQur® Closes $100 Million Series E, Backed by Commercial Momentum and Growing Demand for CeQur Simplicity™ Series E Financing Reflects Sustained Investor Confidence in CeQur’s Commercial Trajectory, Clinical Results, and Growing Demand for a Simpler Approach to Mealtime Insulin CeQur, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced […]

Extended 7-Day Wear and 1-Unit Dosing Clearances, and Two ADA Posters Signal a New Standard for Mealtime Insulin Management CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced two recent FDA clearances for CeQur Simplicity™: extended wear of up to seven days and a new 1-unit (1U) device. […]